Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
暂无分享,去创建一个
F. Mollinedo | C. Gajate | A. Benito | A. Benito | M. Modolell | J. Fernández-Luna | C Gajate | M Modolell | F Mollinedo | J. Fernández-Luna | R Martínez-Dalmau | J L Fernández-Luna | A Benito | B Martín-Martín | B. Martín-Martín | R. Martínez-Dalmau | F. Mollinedo | Belén Martín-Martín | Rosa Martínez-Dalmau | Manuel Modolell
[1] O. Westphal,et al. Antitumoral and other biomedical activities of synthetic ether lysophospholipids. , 1990, Chemical immunology.
[2] F. Mollinedo,et al. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3. , 1993, Biochemical and biophysical research communications.
[3] E. Thiel,et al. Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy. , 1996, Bone marrow transplantation.
[4] W. Vogler,et al. Purging leukemic cells from simulated human remission marrow with alkyl-lysophospholipid. , 1987, Blood.
[5] R. Coffey,et al. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells , 1987, Journal of cellular physiology.
[6] H. Heuer,et al. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. , 1990, Journal of Pharmacology and Experimental Therapeutics.
[7] E. Modest,et al. Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells. , 1993, Biochemical pharmacology.
[8] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[9] L. Verdonck,et al. Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3. , 1995, Leukemia research.
[10] J. Cleveland,et al. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.
[11] K. Jalink,et al. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. , 1992, The EMBO journal.
[12] F. Re,et al. The induction of apoptosis is a common feature of the cytotoxic action of ether‐linked glycerophospholipids in human leukemic cells , 1994, International journal of cancer.
[13] V. Lew,et al. Suramin: a potent ATPase inhibitor which acts on the inside surface of the sodium pump. , 1973, Biochimica et biophysica acta.
[14] F. Re,et al. Induction of apoptosis in human leukemic cells by the ether lipid 1‐octadecyl‐2‐methyl‐RAC‐glycero‐3‐ phosphocholine. A possible basis for its selective action , 1993, International journal of cancer.
[15] W. Berdel,et al. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. , 1993, Cancer research.
[16] M. Erisman,et al. Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies , 1984, Molecular and cellular biology.
[17] M. Rola-Pleszczynski,et al. Human PAF receptor gene expression: induction during HL-60 cell differentiation. , 1991, Biochemical and biophysical research communications.
[18] C. Rock,et al. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine , 1995, The Journal of Biological Chemistry.
[19] T. Dexter,et al. Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells. , 1990, Cancer research.
[20] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[21] Z. Oltvai,et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.
[22] A. Morris,et al. Rapid intracellular calcium changes in U937 monocyte cell line: transient increases in response to platelet-activating factor and chemotactic peptide but not interferon-gamma or lipopolysaccharide. , 1987, Immunology.
[23] U. Wollert,et al. Spectroscopic studies on the complex formation of suramin with bovine and human serum albumin. , 1976, Biochimica et biophysica acta.
[24] F. Mollinedo,et al. The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells. , 1994, The Biochemical journal.
[25] W. Berdel,et al. Autologous bone marrow transplantation with alkyl-lysophospholipid-purged marrow. , 1993, Journal of hematotherapy.
[26] R. Andreesen,et al. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids. , 1979, Cancer research.
[27] F. Mollinedo,et al. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes. , 1993, The Biochemical journal.
[28] F. Snyder,et al. HL-60 cells become resistant towards antitumor ether-linked phospholipids following differentiation into a granulocytic form. , 1988, Biochemical and biophysical research communications.
[29] D. Kunz,et al. The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. , 1992, The Journal of biological chemistry.
[30] M. Clarke,et al. The Bcl-2 family of proteins: regulators of cell death and survival. , 1994, Trends in cell biology.
[31] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[32] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[33] W. Vogler,et al. Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs. , 1994, Leukemia & lymphoma.
[34] E. Modest,et al. Animal cell mutants unable to take up biologically active glycerophospholipids. , 1995, Journal of lipid research.
[35] C. Heldin,et al. Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Green,et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.
[37] G. Evan,et al. Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.
[38] S. Korsmeyer,et al. Molecular thanatopsis: a discourse on the BCL2 family and cell death. , 1996, Blood.